Recap: Akebia Therapeutics Q4 Earnings

Akebia Therapeutics AKBA reported its Q4 earnings results on Tuesday, March 1, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Akebia Therapeutics missed estimated earnings by 21.21%, reporting an EPS of $-0.4 versus an estimate of $-0.33.

Revenue was up $2.91 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 3.62% drop in the share price the next day.

Here's a look at Akebia Therapeutics's past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.32 -0.32 -0.36 -0.4
EPS Actual -0.34 -0.51 -0.45 -0.6
Revenue Estimate 49.67M 52.88M 42.84M 51.16M
Revenue Actual 48.76M 52.91M 52.30M 56.70M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKBA Logo
AKBAAkebia Therapeutics Inc
$2.891.05%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
97.61
Growth
28.97
Quality
Not Available
Value
24.14
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Comments
Loading...